AUTHOR

Daniel Goldman

Daniel has spent most of his nearly two-decade career designing and building scalable software systems for scientists, both at StackWave and as part of teams in the biopharmaceutical industry.

Stories by Daniel


StackWave Affinity

StackWave Affinity 2022 Year in Review

Every year, StackWave delivers a steady stream of improvements to our Affinity antibody discovery solution, and 2022 was no exception.

DrugOps

DrugOps (Part 2): Shared Ownership

Develop Shared Ownership to collectively empower and engage your team in accomplishing company, team, and individual goals.

DrugOps

Intro to DrugOps

Three principles to tame complexity in drug discovery. DrugOps emphasizes Shared Ownership, Workflow Automation, and Rapid Feedback.

StackWave Affinity™

Whether you're a CRO making customer deliveries, a start-up advancing towards IND, or an established biopharma supporting multiple programs at once, Affinity supports every team, at every step, on a single platform, for a single price.

Download the StackWave Affinity LIMS presentation

Sign up for notifications